Semaglutide primarily targets GLP-1 alone, while Tirzepatide combines GLP-1 and GIP receptor activity, giving it a broader incretin signalling profile
The key distinction is that adaptive muscle soreness improves over time, does not interfere significantly with daily activities, and is not accompanied by concerning symptoms like dark urine, severe weakness, or systemic signs like fever
Lipid metabolism Semaglutide and Liraglutide effects on lipid metabolism GLP-1RA drugs have been associated with reduced food intake and body weight loss (39)
Lower insulin requirements are also noted in real-world studies ( 4.2.2 RCTs In RCTs, insulin dose reductions were observed with the addition of GLP-1RA (61) ( Table 1 )
Patients often hear that these peptides may support injury recovery, tendon healing, inflammation balance, or tissue repair